INCY (STOCKS)
Incyte Genomics Inc
$104.060000
-4.470000 (-4.12%)
Prev close: $108.530000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- William J. Meury
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $20,789.33M
- Employees
- 2,617
- P/E (TTM)
- 15.35
- P/B (TTM)
- 3.86
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
8
Strong Buy
8
Buy
18
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$1.81 | $1.40 | +0.4116 | +29.43% |
|
Dec 2025 (Q4)
|
$1.80 | $1.97 | -0.1663 | -8.46% |
|
Sep 2025 (Q3)
|
$2.26 | $1.69 | +0.5702 | +33.74% |
|
Jun 2025 (Q2)
|
$1.57 | $1.50 | +0.0707 | +4.72% |
Financial Statements
| Assets | $7.34B |
| Current Assets | $5.48B |
| Inventory | $115.62M |
| Other Current Assets | $5.37B |
| Noncurrent Assets | $1.85B |
| Fixed Assets | $720.17M |
| Other Non-current Assets | $1.13B |
| Liabilities | $1.72B |
| Current Liabilities | $1.49B |
| Accounts Payable | $228.62M |
| Wages | $124.92M |
| Other Current Liabilities | $1.14B |
| Noncurrent Liabilities | $226.62M |
| Equity | $5.62B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $5.62B |
| Liabilities And Equity | $7.34B |